Pathogenic mutations in ACADS have been identified in patients with SCAD deficiency, whereas others carry two ACADS polymorphisms (G625A and C511T) that are considered susceptibility variants [116,117]. This evidence concerns the gene ACADS and short chain acyl-CoA dehydrogenase deficiency.